Follow
Susana Hernandez Prieto
Susana Hernandez Prieto
Unknown affiliation
Verified email at hmhospitales.com
Title
Cited by
Cited by
Year
Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior
B Perez Villamil, A Romera Lopez, S Hernandez Prieto, G Lopez Campos, ...
BMC cancer 12, 1-13, 2012
1462012
Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II
J Ruiz, A Martínez, S Hernández, H Zimman, M Ferrer, C Fernández, ...
Histology and histopathology, 2010
632010
Neoadjuvant atezolizumab+ chemotherapy in resectable non-small cell lung cancer (NSCLC).
CA Shu, C Grigg, C Chiuzan, RF Garofano, V Patel, S Hernandez, T Negri, ...
Journal of Clinical Oncology 36 (15_suppl), 8532-8532, 2018
612018
Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non–small cell lung carcinoma: the ROSING study
E Conde, S Hernandez, R Martinez, B Angulo, J De Castro, ...
Journal of Thoracic Oncology 14 (12), 2120-2132, 2019
572019
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas
E Conde, S Hernandez, M Prieto, R Martinez, F Lopez-Rios
Expert review of molecular diagnostics 16 (6), 707-713, 2016
492016
3p21, 5q21, 9p21 and 17p13. 1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia.
J Sanz-Ortega, S Hernández, MC Saez, E Sierra, G Sanz-Ortega, ...
Hepato-gastroenterology 50 (50), 404-407, 2003
442003
A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer
S Hernández-Prieto, A Romera, M Ferrer, JL Subiza, JA López-Asenjo, ...
Clinical and Translational Oncology 17, 330-338, 2015
382015
Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability
P Ortega, A Morán, C de Juan, C Frías, S Hernández, JA López-Asenjo, ...
Clinical cancer research 14 (4), 995-1001, 2008
382008
Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer
E Conde, S Hernandez, E Sanchez, RM Regojo, C Camacho, M Alonso, ...
Archives of Pathology & Laboratory Medicine 145 (8), 1031-1040, 2021
362021
3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation
J Sanz Ortega, C Valor, MC Saez, L Ortega, E Sierra, J Poch, ...
Histology and histopathology, 2003
362003
Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care
I Del-Cura González, F García-de-Blas González, TS Cuesta, ...
BMC public health 11, 1-8, 2011
342011
Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care
IDC González, FGB González, TS Cuesta, JM Fernández, ...
BMC Public Health 11, 63, 2011
212011
Aligning digital CD8+ scoring and targeted next‐generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early‐stage …
E Conde, A Caminoa, C Dominguez, A Calles, S Walter, B Angulo, ...
Histopathology 72 (2), 270-284, 2018
182018
CIPROFLOXACIN IN TREATMENT OF NONSPECIFIC VAGINITIS
O Carmona, R KOBELT, S HERNANDEZ, I GONZALEZ, LH GRAFFE
ACTA PHYSIOLOGICA ET PHARMACOLOGICA LATINOAMERICANA 37 (1), 72-72, 1987
141987
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy.
S Khan, J Lutzky, AN Shoushtari, JM Jeter, C Chiuzan, N Sender, ...
Journal of Clinical Oncology 38 (15_suppl), 10075-10075, 2020
132020
Evaluación, formación e innovación docente: respuesta a la mejora de calidad universitaria
MJ Rodríguez, S Olmos, F Ortega, P Torrijos, S Hernández
Revista CIDUI 2, 2014
122014
Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition
T Fernández-Marcelo, A Morán, C De Juan, I Pascua, J Head, A Gómez, ...
Oncology 82 (3), 153-164, 2012
112012
Screening for ROS1 fusions in patients with advanced non-small cell lung carcinomas using the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody
E Conde, S Hernandez, A Benito, A Caminoa, P Garrido, F Lopez-Rios
Expert Review of Molecular Diagnostics 21 (5), 437-444, 2021
102021
Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice
J Zugazagoitia, J Puente, JL González-Larriba, A Manzano, M Sotelo, ...
Oncology 84 (5), 255-264, 2013
92013
Quilty effect areas are frequently associated with endocardial C4d deposition
LC Cano, AA Arteta, R Fernández, JAL García-Asenjo, S Hernández, ...
The Journal of heart and lung transplantation 27 (7), 775-779, 2008
92008
The system can't perform the operation now. Try again later.
Articles 1–20